Methods and apparatuses for modeling, simulating, and treating hereditary angioedema
US2020348311A1
Methods for quantitation of functional c1 esterase inhibitor (fc1-inh)
WO2020210446A1
Lateral flow immunoassay for measuring functional c1-esterase inhibitor (c1-inh) in plasma samples
US2020340987A1
Lateral flow immunoassay for measuring functional c1-esterase inhibitor (c1-inh) in plasma samples
US2020317815A1
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
WO2020047352A1
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP3661922A1
Inhibitors of plasma kallikrein and uses thereof
BR112019005172A2
method and kit for analyzing a sample
WO2018053247A1
Metabolite biomarkers for diseases associated with the contact activation system
BR112019005179A2
method and kit for analyzing a sample
KR20180134838A
Peptide quantification assay to distinguish long-chain high molecular weight kininogen (HMWK) and truncated HMWK
US2018362664A1
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
KR20180093897A
Immunoassay for detection of truncated high molecular weight kininogen
AU2016244213A1
Plasma kallikrein binding proteins
AU2016234978A1
Multi-chain eukaryotic display vectors and uses thereof
AU2016225923A1
Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries
CN108135547A
For assessing the vacuum blood collection tube containing protease inhibitors of contact system activation
CA2993026A1
A monoclonal antibody inhibitor of factor xiia
WO2016160926A1
Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack
US2018118851A1
Bispecific antibodies against plasma kallikrein and factor xii
